Simply Wall St.1d agoneutral
Novavax (NVAX) Looks Cheap After Sanofi Milestone And Stronger Q3 ResultsNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
102last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires2d agobullish
B. Riley Adjusts Price Target on Novavax to $16 From $18, Keeps Buy RatingGuruFocus.com3d agoneutral
Novavax Inc (NVAX) (Q3 2026) Earnings Call Highlights: Sanofi Milestone Lifts Revenue Outlook ...StockStory3d agoneutral
Novavax’s (NASDAQ:NVAX) Q3 2026: strong sales, guides for strong full-year salesPR Newswire3d agoneutral
Novavax Reports Third Quarter 2026 Financial Results and Operational HighlightsSimply Wall St.3d agoneutral
Sanofi Stock And Why Earnings Guidance Raised Matters For ShareholdersMT Newswires10d agoneutral
Novavax Earns $125 Million Milestone Payment From Sanofi's Phase 3 Vaccine Trial in EuropePR Newswire10d agoneutral
Novavax to Report Third Quarter 2026 Financial Results on November 5, 202624/7 Wall St.11d agobullish
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher